COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,677 | +15.0% | 970 | +10.6% | 0.00% | – |
| Q2 2023 | $18,843 | -91.9% | 877 | -91.0% | 0.00% | – |
| Q1 2023 | $233,805 | +64.7% | 9,751 | +59.9% | 0.00% | – |
| Q4 2022 | $142,000 | +52.7% | 6,099 | +4.3% | 0.00% | – |
| Q3 2022 | $93,000 | +564.3% | 5,846 | +620.8% | 0.00% | – |
| Q2 2022 | $14,000 | -12.5% | 811 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | +33.3% | 811 | +17.4% | 0.00% | – |
| Q4 2021 | $12,000 | -40.0% | 691 | -33.5% | 0.00% | – |
| Q3 2021 | $20,000 | -25.9% | 1,039 | -9.6% | 0.00% | – |
| Q2 2021 | $27,000 | +8.0% | 1,149 | +7.2% | 0.00% | – |
| Q1 2021 | $25,000 | -16.7% | 1,072 | -30.4% | 0.00% | – |
| Q4 2020 | $30,000 | +30.4% | 1,541 | +35.3% | 0.00% | – |
| Q3 2020 | $23,000 | -8.0% | 1,139 | -18.4% | 0.00% | – |
| Q2 2020 | $25,000 | +127.3% | 1,395 | +104.5% | 0.00% | – |
| Q1 2020 | $11,000 | – | 682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |